Streetbeat News

Stock Prices

ERIC

IBM

STX

Wall Street's most accurate analysts recommend holding three high-yield dividend tech stocks: International Business Machines Corporation (IBM), Telefonaktiebolaget LM Ericsson (ERIC), and Seagate Technology Holdings (STX). These stocks have dividend yields of 5.24%, 5.15%, and 4.57%, respectively.

Portfolio Pulse from Lisa Levin

May 26, 2023 | 11:26 am

BTCUSD

A Bitcoin whale moved over 31,000 Bitcoins worth over $822 million from their cold wallets, which had been inactive since late 2022. This follows unknown Bitcoin wallets transferring over $1 billion worth of Bitcoin in six massive transactions earlier on Wednesday.

Portfolio Pulse from Mehab Qureshi

May 26, 2023 | 11:18 am

BBY

NVDA

QQQ

SPY

US stocks are set to open modestly higher as debt talks continue and the June 1 deadline for a potential default approaches. Analyst Quincy Crosby sees headwinds easing due to positive sentiment from Nvidia's earnings, Best Buy's upbeat results, and headlines pointing to debt ceiling resolution.

Portfolio Pulse from Shanthi Rexaline

May 26, 2023 | 11:17 am

WDAY

Workday Inc (NASDAQ:WDAY) reported better-than-expected Q1 results with revenue of $1.68 billion, up 17.4% YoY, and earnings of $1.31 per share. The company also appointed Zane Rowe as CFO. Following the announcement, several analysts raised their price targets on Workday shares.

Portfolio Pulse from Lisa Levin

May 26, 2023 | 11:01 am

ABG

Asbury Automotive announces a new stock repurchase authorization of $250M. Year-to-date 2023, the company has repurchased around 1.1 million shares for approximately $211 million, with no remaining availability under the previous program.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 10:52 am

BAH

Booz Allen Hamilton expects FY24 revenue growth of 7.0-11.0% and adjusted EPS of $4.80-$4.95, compared to the consensus estimate of $4.88.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 10:51 am

LAZ

Lazard has announced leadership changes, appointing Peter R. Orszag as CEO and Kenneth M. Jacobs as Executive Chairman, effective October 1, 2023.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 10:42 am

REGN

Regeneron Pharmaceuticals announced updated data from two Phase 2 expansion dose cohorts of linvoseltamab in patients with relapsed/refractory multiple myeloma, showing a 71% response rate. The LINKER-MM1 trial will form the basis of planned submissions to regulatory authorities, including the FDA, later this year. Regeneron also announced data from three independent cohorts of fianlimab and Libtayo in adults with advanced melanoma, demonstrating clinically meaningful and durable results.

Portfolio Pulse from Vandana Singh

May 26, 2023 | 10:40 am

PDSB

PDS Biotech shares rose 18% premarket after announcing a 12-month survival rate of 87% for head and neck cancer patients treated with PDS0101 in combination with Keytruda.

Portfolio Pulse from Charles Gross

May 26, 2023 | 10:34 am

HIBB

Hibbett Sports has revised its FY24 sales guidance to be flat to up around 2.0%, compared to its prior guidance of up mid-single digit. The company also expects diluted EPS of $7.00-$7.75, down from the previous guidance of $9.50-$10.00.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 10:34 am